Endymed Ltd Share Price TEL AVIV STOCK EXCHANGE

Equities

ENDY

IL0011010217

Advanced Medical Equipment & Technology

Market Closed - TEL AVIV STOCK EXCHANGE 07:54:14 27/06/2024 pm IST 5-day change 1st Jan Change
296.3 ILa +2.35% Intraday chart for Endymed Ltd +6.66% +2.53%
Dynamic Chart
Endymed Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Endymed Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Endymed Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Endymed Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Endymed Ltd Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Endymed Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Endymed Ltd Receives FDA Approval for Marketing and Sales of its Brand-New Laser Based Hair Removal Device CI
Endymed Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Endymed Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Endymed Ltd Appoints Bill Scott as US Subsidiary President, Endymed Inc CI
Endymed Ltd Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Endymed Ltd Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Endymed Ltd Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Endymed Medical Ltd. announced that it has received $7 million in funding from OHMK Medical Technology Co. Ltd. CI
Endymed Medical Ltd. announced that it expects to receive $7 million in funding from OHMK Medical Technology Co. Ltd. CI
More news
1 week+6.66%
Current month+0.99%
1 month+5.82%
3 months-10.21%
6 months-1.92%
Current year+2.53%
More quotes
1 week
272.00
Extreme 272
300.00
1 month
272.00
Extreme 272
300.00
3 years
229.80
Extreme 229.8
838.00
5 years
168.00
Extreme 168
838.00
10 years
138.00
Extreme 138
1 958.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 30/15/30
Director of Finance/CFO 45 22/18/22
Chief Operating Officer 43 01/23/01
Members of the board TitleAgeSince
Chief Executive Officer 55 30/15/30
Director/Board Member 46 05/21/05
Director/Board Member 66 17/22/17
More insiders
Date Price Change
27/24/27 296.3 +2.35%
26/24/26 289.5 -1.46%
25/24/25 293.8 -0.10%
24/24/24 294.1 0.00%
23/24/23 294.1 +5.87%

Delayed Quote TEL AVIV STOCK EXCHANGE, June 27, 2024 at 07:54 pm IST

More quotes
Endymed Ltd, formerly Applisonix Ltd, is an Israel-based company. The Company operated for two years under the Ma'ayan Technology Incubator Group, an investment group for high technology premature companies. The Company has three wholly-owned subsidiaries, two in Israel and one subsidiary in Hong Kong. The Company, through wholly-owned subsidiary CureLight Medical Ltd, develops, manufactures and markets ultrasound hair removal equipment based on an in-house technology for both professionals and home users. Starting from January 2012, through wholly owned subsidiary EndyMed Medical Ltd, the Company is also engaged in design, development and marketing of aesthetic treatment equipment based on radiofrequency technology, which is a solution for fractional skin resurfacing, wrinkle treatment, skin tightening, scar treatment and body contouring.
More about the company